Nvigen (United States)

Revolutionizing Health Care with Modern Nanoparticles

NVIGEN is revolutionizing personalized medicine with highly accurate and NGS data efficient assays that provide integrative DNA, RNA, protein, cell, exosome information. Our mission is to improve health through our open platform of molecularly engineered nanoparticles and data-driven insights that help understand biological processes and reduce risks for aging, cancer, cardiovascular, neurodegenerative, and diabetic conditions.The NVIGEN X - Cancer Precision Profiling Test, now available for research use, supports early detection, monitoring, and treatment of cancer through accessible liquid biopsy tests. In line with our OpenVigen philosophy, we offer MagVigen and MyQuVigen nanoparticles to the biotech community, enabling high-sensitivity and high specificity immunoassays, genomic testing, molecular and cellular capture, and multiomics analysis. These products empower advancements in biomarker profiling, point-of-care testing, T-cell therapy, and precision diagnostics.